SLC40A1 and Alzheimer disease: Looking carefully at the NRI data, it appeared that in the Mtp-1 cohort, the improvement linked to PLMR was mainly significant for AD patients (“up if AD”), while in Mtp-2, it was both for AD and NAD (“down if NAD”) patients.